We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.40 | 0.20% | 1,708.60 | 1,708.60 | 1,708.80 | 1,713.00 | 1,699.40 | 1,701.60 | 11,522,668 | 16:29:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.27 | 70.34B |
Date | Subject | Author | Discuss |
---|---|---|---|
24/2/2021 15:12 | They are the primary calls and will either deliver value, or not. And there have been two oncology pipeline setbacks recently. | essentialinvestor | |
24/2/2021 15:10 | ....but we are told that it is so good that women are getting into these positions. | semper vigilans | |
24/2/2021 15:08 | Spud, I'm the last person to stand in her corner, but what I would say fwiw is EW has effectively made two big calls - CH split and a huge investment in oncology. It's those two decision that will determine the success, or otherwise, of her tenure. That should be much clearer by the end of 2022. | essentialinvestor | |
24/2/2021 15:03 | I asked this question a few weeks ago and got zero response but can anyone tell me what positives EW has had on the Company? Come on chaps, she must have a few fans here!!spud | spud | |
24/2/2021 15:00 | It's PC correctness gone mad. | meijiman | |
24/2/2021 14:52 | reading this account of the scotia collapse in 2001 i was amused to see this : "Dr Horrobin was considered too fond of "hippy" projects such as primrose oil. The City questioned why his wife, whose most advanced qualification was a BA in English and women's studies, was in charge of Scotia's drug discovery division." i then checked la walmsley's wiki page - "has an MA in Classics and Modern Languages from Oxford University". Walmsley's running not simply one division in a chancey biotech company whose market cap at it's height was only £600m, but is head of a huge pharma multinational. This stinks like hell. | unastubbs | |
24/2/2021 14:18 | All very well that an institution, overseas or otherwise, increases its holding , having held for ten years etc but they have lost clients' serious monies in that period. Where is the pressure for executive change? Fundamentals and product news flow are likely to drive this share up or down and the news flow has been pretty unimpressive for far too long so the upside appears quite remote. No one seems to be able to get a grip. This share price maybe edging along the long term bottom but there is minimal indication from anywhere of any significant change in direction. Very Frustrating! | gregmorg | |
24/2/2021 13:55 | They have held some for 10 years. | encarter | |
24/2/2021 13:19 | Investment fund, shame not a hedge fund, they would probably want a seat on the board, shake them up. | montyhedge | |
24/2/2021 13:15 | Your wrong there look at the rns seems straight in with 5% holding. | montyhedge | |
24/2/2021 12:59 | They have just been buying more of an established position, have been large holders for the last few years | daneswooddynamo | |
24/2/2021 12:52 | 253,464,108 SHARES BOUGHT !! all whilst useless UK retail punters have been caving in! Almost in profit on my own measly 18K shares! | eurofox | |
24/2/2021 12:49 | Yes - Dodge & Cox. Sounds like a Radio breakfast show duo until you read that they managed to accrue a rather healthy £3bn+ of stock. spud | spud | |
24/2/2021 12:39 | See the RNS - some US mob have taken a 5% position in GSK, thanks to all the weak retail holders selling into well managed order book stuffing | eurofox | |
24/2/2021 12:36 | Not loading up yet, Astra ex div soon going to bring that down of course below 6950p, so sentiment may bring other pharma's down. | montyhedge | |
24/2/2021 09:54 | Diana Conrad, senior vice president of Human Resources, buys 3,400 American Depositary Shares at USD34.54... | tradermichael | |
24/2/2021 08:33 | Just needs to stabilise. Freefall will find a level shortly imo. | supermarky | |
23/2/2021 19:36 | Down in the USA now again | buywell2 | |
23/2/2021 17:23 | glaxosmithkline - the recovery...that's the name of this thread - created in 2007! | unastubbs | |
23/2/2021 17:07 | Ohh did it rise today, there's a surprise. Dyor | slinkyj | |
23/2/2021 14:18 | "Tbh you could say that about nearly every company on the FTSE 100. Unless a stock has been lower since the IPO - they will all have support lower down." ==================== True but it does have a habit of returning to the same base level. 2002,2003,2008 and 2009. The point I was making was that when it has a major reversal it drops to the base level. It's currently revisiting the September 2015 low which was also the February 2018 low. On both occasions it bounced up and may do so again but if support fails and it closes below that level then the probability of dropping to the base level is high. | bracke | |
23/2/2021 13:34 | Another 80p on its way this year. The next Feb see where we are on dividends. | montyhedge | |
23/2/2021 13:25 | Was the morning the low?. Too soon to say probably. | essentialinvestor | |
23/2/2021 13:25 | Add 23p on ex div last week not to bad. But if worried about the split why you holding GSK.It's the best thing ever. | montyhedge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions